Simplex Trading
CLRB icon

Simplex Trading’s Cellectar Biosciences CLRB Stock Holding History

Simplex Trading’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150
Closed -$9K – 8622
2024
Q3 		$9K Sell
150
-17
-10% -$1.12K ﹤0.01% 7231
2024
Q2 		$12K Sell
167
-436
-72% -$41.8K ﹤0.01% 7281
2024
Q1 		$72K Buy
+603
New +$65.3K ﹤0.01% 5926

Other funds holding CLRB

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's CLRB Position: Q3 2025 in Review

Simplex Trading sold out of Cellectar Biosciences (CLRB) in Q3 2025, closing a stake of 238 shares — an estimated $1K sold.

Simplex Trading first reported a position in CLRB in Q1 2024 and held it in 6 quarters. The position peaked at $54K in Q1 2025. 21 funds tracked by Wall St. Rank hold CLRB as of Q3 2025.

  • Simplex Trading reported no remaining Cellectar Biosciences position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 238 Cellectar Biosciences shares in Q3 2025, an estimated $1K.
  • Simplex Trading first reported a position in Cellectar Biosciences in Q1 2024 and held it in 6 quarters.
  • Simplex Trading's Cellectar Biosciences position peaked at $54K in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.